## Abstract Interferonβgamma (IFNβΞ³) is a pleiotropic cytokine that is critically involved in the pathogenesis of inflammatory demyelinating diseases. There is strong evidence that IFNβΞ³ can function as a distinct and independent injurious factor to oligodendrocyte progenitor cells (OPCs). The intr
Effects of lipopolysaccharide on oligodendrocyte progenitor cells are mediated by astrocytes and microglia
β Scribed by Yi Pang; Zhengwei Cai; Philip G. Rhodes
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 678 KB
- Volume
- 62
- Category
- Article
- ISSN
- 0360-4012
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Previous work has indicated that BDNF increases the differentiation of basal forebrain (BF) oligodendrocytes (OLGs) in culture through the mediation of trkB and the MAPK pathway (Du et al. [ 2006a, b] Mol. Cell. Neurosci. 31:366β375; J. Neurosci. Res. 84:1692β1702). In the present work,
## Abstract The extracellular matrix (ECM) is a component of neural cell niches and regulates multiple functions of diverse cell types. To date, limited information is available concerning its biological effects on the growth properties of oligodendrocyte progenitor cells (OPCs). In the present stu
## Abstract Multiple studies have shown that migration, proliferation, and differentiation of oligodendrocyte (OL) lineage cells are influenced by fibroblast growth factorβ2 (FGFβ2) signaling through its receptors (FGFR) FGFRβ1, FGFRβ2, and FGFRβ3. We report the effectiveness and specificity of a u
The pteridine neopterin (NP) was shown to be produced by monocytes and is known to be a useful marker of immunological activation, although, its biological activity is still unclear. Recently, we found that intravenous administration of NP increased the numbers of blood leukocytes, and granulocyte-m
In this study, we investigated the mechanism of synergistic effects of cytokine and hyperthermia on cytotoxicity in HT-29. When cells were heated at 42Β°C in the presence of recombinant human tumor necrosis factor (rhTNF-a), recombinant interferon-gamma (rhlFN-y), or in a combination of both, a syner